Search Login Register

Osteonecrosis (Kienbock's Disease) Summary

Description: Death of a bone or part of a bone, either atraumatic or posttraumatic.

Also Known As: Kienbock's Disease; Kienbock Disease; Kienboeck Disease; Kienboeck's Disease; Bone Aseptic Necrosis Show All >>

Networked: 3149 relevant articles (112 outcomes, 363 trials/studies) for this Disease

Key Drugs and Agents for Osteonecrosis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Diphosphonates : 6 outcomes 58 studies in 679 results : IBA
  2. zoledronic acid (zoledronate) : 4 outcomes 17 studies in 146 results : FDA 13
  3. Oxygen : 4 outcomes 4 studies in 17 results : IBA
  4. Alendronate (Alendronate Sodium) : 3 outcomes 10 studies in 55 results : FDA 18 Generic
  5. Adrenal Cortex Hormones (Corticosteroids) : 2 outcomes 8 studies in 124 results : IBA
  6. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor) : 2 outcomes 6 studies in 32 results : IBA
  7. Nitrogen : 2 outcomes 2 studies in 58 results : IBA
  8. pamidronate (APD) : 2 outcomes 2 studies in 27 results : FDA 16 Generic
  9. Lovastatin (Mevacor) : 2 outcomes 2 studies in 6 results : FDA 14 Generic
  10. Tantalum : 1 outcome 6 studies in 20 results : IBA
Show All >>

Diseases Related to Osteonecrosis

  1. Osteoarthritis
  2. Pain (Aches)
  3. Infection
  4. Sickle Cell Anemia (Hemoglobin S Disease)
  5. Joint Diseases (Joint Disease)
Show All >>

Key Therapies for Osteonecrosis

Efficacy Chart >>
  1. Decompression : 16 outcomes 27 studies in 189 results
  2. Arthroplasty : 15 outcomes 43 studies in 338 results
  3. Transplants (Transplant) : 7 outcomes 17 studies in 178 results
  4. Osteotomy : 5 outcomes 18 studies in 159 results
  5. Transplantation (Transplant Recipients) : 4 outcomes 8 studies in 77 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.